Detalhe da pesquisa
1.
Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Brain Behav Immun
; 62: 24-29, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28179106
2.
Aggrecan is required for growth plate cytoarchitecture and differentiation.
Dev Biol
; 396(2): 224-36, 2014 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25446537
3.
The role of IDO in brain tumor immunotherapy.
J Neurooncol
; 123(3): 395-403, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25519303
4.
Exogenous activation of Wnt/ß-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.
Alcohol Alcohol
; 49(4): 399-408, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24627571
5.
Age-stratified comorbid and pharmacologic analysis of patients with glioblastoma.
Brain Behav Immun Health
; 38: 100753, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600951
6.
Ketorolac administration does not delay early fracture healing in a juvenile rat model: a pilot study.
J Pediatr Orthop
; 33(4): 415-21, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23653032
7.
Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence.
Clin Cancer Res
; 29(23): 4973-4989, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37725593
8.
Acute alcohol exposure impairs fracture healing and deregulates ß-catenin signaling in the fracture callus.
Alcohol Clin Exp Res
; 36(12): 2095-103, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22691115
9.
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancer.
Brain Behav Immun Health
; 21: 100449, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35368609
10.
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
J Immunother Cancer
; 10(7)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35902132
11.
Identification and Characterization of a Novel Indoleamine 2,3-Dioxygenase 1 Protein Degrader for Glioblastoma.
J Med Chem
; 65(23): 15642-15662, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36410047
12.
Alcohol exposure and mechanisms of tissue injury and repair.
Alcohol Clin Exp Res
; 35(3): 392-9, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21118273
13.
Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.
Clin Cancer Res
; 27(23): 6514-6528, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34479957
14.
Glioblastoma as an age-related neurological disorder in adults.
Neurooncol Adv
; 3(1): vdab125, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647022
15.
A retrospective survival analysis of Glioblastoma patients treated with selective serotonin reuptake inhibitors.
Brain Behav Immun Health
; 22020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32190845
16.
Immunosuppressive IDO in Cancer: Mechanisms of Action, Animal Models, and Targeting Strategies.
Front Immunol
; 11: 1185, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32612606
17.
Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma.
Clin Cancer Res
; 26(19): 5232-5245, 2020 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32546647
18.
Quantification of IDO1 enzyme activity in normal and malignant tissues.
Methods Enzymol
; 629: 235-256, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727243
19.
The interplay among psychological distress, the immune system, and brain tumor patient outcomes.
Curr Opin Behav Sci
; 28: 44-50, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31049368
20.
Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017).
Oncoimmunology
; 8(3): 1548242, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723577